Tenaya Therapeutics (TNYA) Institutional Ownership $1.24 +0.06 (+5.08%) Closing price 04:00 PM EasternExtended Trading$1.24 0.00 (0.00%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tenaya Therapeutics (NASDAQ:TNYA)CurrentInstitutional OwnershipPercentage90.54%Number ofInstitutional Buyers(last 12 months)38TotalInstitutional Inflows(last 12 months)$15.69MNumber ofInstitutional Sellers(last 12 months)15TotalInstitutional Outflows(last 12 months)$6.70M Get TNYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Tenaya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data TNYA Institutional Buying and Selling by Quarter Tenaya Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc412,500$252K0.0%N/A0.253% 8/15/2025 Bank of America Corp DE52,855$32K0.0%-43.6%0.032% 8/14/2025 Jane Street Group LLC376,068$230K0.0%+1,958.7%0.231% 8/14/2025 Cerity Partners LLC110,336$67K0.0%+403.5%0.068% 8/13/2025 Marshall Wace LLP148,089$90K0.0%N/A0.091% 8/8/2025 Geode Capital Management LLC1,230,594$752K0.0%-10.5%0.757% 8/6/2025 Savant Capital LLC85,283$52K0.0%N/A0.052% 7/25/2025 CWM LLC90,087$55K0.0%+25.2%0.055% 6/27/2025 Goldman Sachs Group Inc.211,171$120K0.0%-31.0%0.130% 5/16/2025 Woodline Partners LP5,916,167$3.37M0.0%+30,563.2%6.755% Get the Latest News and Ratings for TNYA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tenaya Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Goldman Sachs Group Inc.211,171$120K0.0%-31.0%0.241% 5/16/2025 AQR Capital Management LLC775,657$442K0.0%N/A0.886% 5/15/2025 DAFNA Capital Management LLC47,319$27K0.0%N/A0.054% 5/14/2025 Ieq Capital LLC167,320$95K0.0%N/A0.191% 5/14/2025 Comerica Bank88,177$50K0.0%N/A0.101% 5/13/2025 Callan Family Office LLC88,177$50K0.0%N/A0.101% 5/12/2025 Nuveen LLC226,202$129K0.0%N/A0.258% 5/12/2025 Virtu Financial LLC135,502$77K0.0%+29.4%0.155% 5/5/2025 HighPoint Advisor Group LLC51,500$29K0.0%-32.8%0.059% 5/1/2025 CWM LLC71,945$41K0.0%+14,231.7%0.082% 4/16/2025 Wealth Enhancement Advisory Services LLC58,547$33K0.0%N/A0.067% 2/17/2025 Woodline Partners LP19,294$28K0.0%N/A0.024% 2/17/2025 Squarepoint Ops LLC30,991$44K0.0%-85.0%0.039% 2/17/2025 Two Sigma Investments LP44,771$64K0.0%-18.2%0.057% 2/17/2025 Trustees of Columbia University in the City of New York291,828$417K0.1%N/A0.368% 2/17/2025Nuveen Asset Management LLC345,192$494K0.0%+25.2%0.436% 2/17/2025 Millennium Management LLC154,228$221K0.0%-53.1%0.195% 2/17/2025 Ground Swell Capital LLC22,262$32K0.0%N/A0.028% 2/17/2025 Deutsche Bank AG129,319$185K0.0%+304.1%0.163% 2/17/2025 Bank of America Corp DE147,458$211K0.0%-6.9%0.186% 2/14/2025 Northern Trust Corp472,479$676K0.0%+6.2%0.596% 2/14/2025 Price T Rowe Associates Inc. MD136,234$196K0.0%-95.5%0.172% 2/14/2025 Hsbc Holdings PLC31,141$45K0.0%N/A0.039% 2/14/2025 Dimensional Fund Advisors LP97,981$140K0.0%-14.2%0.124% 2/14/2025 Commerce Bank20,000$29K0.0%N/A0.025% 2/13/2025 XTX Topco Ltd20,687$30K0.0%-58.0%0.026% 2/13/2025 Mariner LLC21,023$30K0.0%N/A0.027% 2/13/2025 Barclays PLC84,627$121K0.0%-68.6%0.107% 2/12/2025 Geode Capital Management LLC1,268,737$1.82M0.0%-2.1%1.602% 2/12/2025 JPMorgan Chase & Co.5,155,596$7.37M0.0%+20,670.3%6.508% 2/11/2025 Sei Investments Co.69,702$100K0.0%N/A0.088% 2/11/2025 Virtu Financial LLC104,712$150K0.0%N/A0.132% 2/10/2025 Commonwealth Equity Services LLC44,500$64K0.0%N/A0.056% 1/24/2025 abrdn plc600,700$859K0.0%+9.1%0.758% 1/24/2025 Spire Wealth Management36,900$53K0.0%N/A0.047% 1/22/2025 Atticus Wealth Management LLC47,762$68K0.0%+56.3%0.060% 1/17/2025 SG Americas Securities LLC41,270$59K0.0%+61.9%0.052% 11/25/2024 Synovus Financial Corp14,600$28K0.0%N/A0.018% 11/16/2024 Geode Capital Management LLC1,296,156$2.50M0.0%+5.4%1.636% 11/15/2024 XTX Topco Ltd49,290$95K0.0%+51.2%0.062% 11/15/2024 Jane Street Group LLC30,806$59K0.0%-52.1%0.039% 11/15/2024 Wellington Management Group LLP294,133$568K0.0%+35.6%0.371% 11/15/2024 State Street Corp1,058,898$2.04M0.0%+0.9%1.337% 11/15/2024 RA Capital Management L.P.6,982,587$13.48M0.2%-8.4%8.814% 11/15/2024 Jacobs Levy Equity Management Inc.337,265$651K0.0%+204.4%0.426% 11/14/2024 Walleye Capital LLC69,479$134K0.0%N/A0.088% 11/13/2024 FMR LLC1,345,938$2.60M0.0%+1.9%1.699% 11/6/2024 Cornercap Investment Counsel Inc.30,222$58K0.0%-52.7%0.038% 11/5/2024 GSA Capital Partners LLP147,932$286K0.0%-18.7%0.188% 10/25/2024 abrdn plc550,700$1.06M0.0%N/A0.698% 10/3/2024 SG Americas Securities LLC25,493$49K0.0%N/A0.032% 8/16/2024 Algert Global LLC23,837$74K0.0%N/A0.030% 8/15/2024 The Manufacturers Life Insurance Company23,199$72K0.0%+43.2%0.030% 8/15/2024 AQR Capital Management LLC13,978$43K0.0%-26.1%0.018% 8/14/2024 Squarepoint Ops LLC120,704$374K0.0%+86.0%0.154% 8/14/2024 Integral Health Asset Management LLC2,325,000$7.21M0.7%+3.3%2.947% 8/9/2024 Renaissance Technologies LLC157,460$488K0.0%+144.1%0.201% 8/9/2024 Dimensional Fund Advisors LP102,026$316K0.0%+42.5%0.130% 8/8/2024 American Century Companies Inc.102,114$317K0.0%+27.7%0.130% 8/6/2024 Acadian Asset Management LLC11,862$36K0.0%-93.4%0.015% 8/1/2024 Rhumbline Advisers78,160$242K0.0%+10.5%0.100% 7/29/2024 Panagora Asset Management Inc.52,744$164K0.0%N/A0.067% 7/26/2024 Bank of New York Mellon Corp237,597$737K0.0%+12.3%0.303% 7/17/2024 Atticus Wealth Management LLC30,563$95K0.0%-45.9%0.039% 5/17/2024 RA Capital Management L.P.5,755,050$30.10M0.4%+4.5%7.329% 5/16/2024 Jacobs Levy Equity Management Inc.168,565$882K0.0%+90.8%0.215% 5/15/2024 Price T Rowe Associates Inc. MD3,346,522$17.50M0.0%-26.4%4.262% 5/10/2024 Acadian Asset Management LLC179,132$936K0.0%-39.2%0.228% 5/10/2024 Vanguard Group Inc.2,862,916$14.97M0.0%+16.4%3.646% 5/7/2024 SG Americas Securities LLC16,194$85K0.0%-36.1%0.021% 5/3/2024 GSA Capital Partners LLP224,051$1.17M0.1%-52.4%0.285% 4/17/2024 Atticus Wealth Management LLC56,512$296K0.1%-18.5%0.072% 3/26/2024 HighPoint Advisor Group LLC70,390$228K0.0%N/A0.090% 2/13/2024 NEOS Investment Management LLC62,159$201K0.0%N/A0.091% 2/2/2024 Bailard Inc.32,900$107K0.0%N/A0.048% 1/30/2024 Cornercap Investment Counsel Inc.81,255$263K0.0%+136.2%0.119% 1/25/2024 Redwood Wealth Management Group LLC16,350$53K0.1%+38.0%0.024% 1/19/2024 Denali Advisors LLC43,300$140K0.0%-15.3%0.064% 1/17/2024 Atticus Wealth Management LLC69,324$225K0.1%-13.4%0.102% 1/12/2024 SG Americas Securities LLC25,337$82K0.0%+20.0%0.037% 12/1/2023 Euclidean Capital LLC1,015,705$2.59M0.6%+10.9%1.491% 11/15/2023 RA Capital Management L.P.6,718,483$17.13M0.3%+10.7%9.864% 11/15/2023 GSA Capital Partners LLP363,493$927K0.1%+194.5%0.534% 11/14/2023 Pale Fire Capital SE28,100$72K0.0%N/A0.041% 11/13/2023 Acadian Asset Management LLC104,069$263K0.0%+501.6%0.153% 11/13/2023 FMR LLC3,186,751$8.13M0.0%-15.1%4.679% 11/7/2023 Barclays PLC249,558$637K0.0%+2,635.8%0.368% 11/7/2023 Jump Financial LLC14,600$37K0.0%-34.5%0.022% 10/27/2023 TD Asset Management Inc219,932$561K0.0%+100.0%0.324% 10/13/2023 SG Americas Securities LLC21,113$54K0.0%N/A0.031% (Data available from 1/1/2016 forward) TNYA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TNYA shares? During the previous two years, 68 institutional investors and hedge funds held shares of Tenaya Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($14.97M), RA Capital Management L.P. ($13.48M), JPMorgan Chase & Co. ($7.37M), Integral Health Asset Management LLC ($7.21M), Woodline Partners LP ($3.37M), FMR LLC ($2.60M), and Euclidean Capital LLC ($2.59M).Learn more on Tenaya Therapeutics' institutional investors. What percentage of Tenaya Therapeutics' stock is owned by institutional investors? 90.54% of Tenaya Therapeutics' stock is owned by institutional investors. Learn more on TNYA's institutional investor holdings. Which institutional investors have been buying Tenaya Therapeutics' stock? Of the 61 institutional investors that purchased Tenaya Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Woodline Partners LP ($5.92M), JPMorgan Chase & Co. ($5.13M), RA Capital Management L.P. ($898.70K), AQR Capital Management LLC ($775.66K), abrdn plc ($600.70K), Marex Group plc ($412.50K), and Vanguard Group Inc. ($403.47K). How much institutional buying is happening at Tenaya Therapeutics? Institutional investors have bought a total of 15,712,820 shares in the last 24 months. This purchase volume represents approximately $15.69M in transactions. Which of Tenaya Therapeutics' major shareholders have been selling company stock? Of the 15 institutional investors that sold Tenaya Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Price T Rowe Associates Inc. MD ($2.89M), RA Capital Management L.P. ($639.76K), Goldman Sachs Group Inc. ($189.67K), Barclays PLC ($184.84K), Squarepoint Ops LLC ($175.43K), Millennium Management LLC ($174.45K), and Geode Capital Management LLC ($172.01K). How much institutional selling is happening at Tenaya Therapeutics? Institutional investors have sold a total of 4,661,279 shares in the last 24 months. This volume of shares sold represents approximately $6.70M in transactions. Related Companies BGM Group Institutional Ownership Sana Biotechnology Institutional Ownership Nurix Therapeutics Institutional Ownership Arbutus Biopharma Institutional Ownership SNDL Institutional Ownership Oculis Institutional Ownership GH Research Institutional Ownership Theravance Biopharma Institutional Ownership ProKidney Institutional Ownership Vir Biotechnology Institutional Ownership This page (NASDAQ:TNYA) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is hereWashington just added $1 trillion to the national debt in less than two months — an astonishing pace of spendi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
